Health Catalyst Named a Leader in Frost & Sullivan’s 2024 US Population Health Management Report

Health Catalyst has been recognized in Frost & Sullivan’s 2024 US Population Health Management (PHM) Report for its innovative approach to improving care quality, patient outcomes, and operational efficiency. Frost & Sullivan cites Health Catalyst’s Population Health Suite—featuring financial and quality benchmarking, administrative support, and advanced analytics—as a significant factor in this acknowledgment.

Highlights from the Report

• Innovation & Growth: Recognized by Frost & Sullivan analysts for driving meaningful progress in value-based care.
• Flexible Solutions: Scalable options meet the needs of healthcare organizations of all sizes.
• Expanded Capabilities: Strategic acquisitions, including CareVive and Lumeon, enhance oncology care management and patient communication.
• Customer-Centric Approach: Continuous solution improvements guided by user feedback and industry trends.

Download the Report

Get a deeper look at the US PHM market and the factors that led to Health Catalyst’s leadership recognition.

‍

‍